These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 7904939

  • 1. Clinical role of d-sotalol and d,l-sotalol in supraventricular arrhythmias, including pre-excitation.
    Daubert C, Mabo P, Gras D, Leclercq C.
    Eur Heart J; 1993 Nov; 14 Suppl H():67-73. PubMed ID: 7904939
    [Abstract] [Full Text] [Related]

  • 2. Efficacy, safety, and tolerance of d-sotalol in patients with refractory supraventricular tachyarrhythmias.
    Sahar DI, Reiffel JA, Bigger JT, Squatrito A, Kidwell GA.
    Am Heart J; 1989 Mar; 117(3):562-8. PubMed ID: 2919535
    [Abstract] [Full Text] [Related]

  • 3. [Sotalol in the Wolff-Parkinson-White syndrome: an electrophysiological and clinical study].
    Inama G, Furlanello F, Vergara G, Guarnerio M, Braito G, Nassivera E.
    G Ital Cardiol; 1992 Jun; 22(6):701-13. PubMed ID: 1426808
    [Abstract] [Full Text] [Related]

  • 4. [Electrophysiologic effect of sotalol in supraventricular tachycardias].
    Borggrefe M, Breithardt G.
    Z Kardiol; 1985 Sep; 74(9):506-11. PubMed ID: 4060828
    [Abstract] [Full Text] [Related]

  • 5. [Sotalol in supraventricular tachycardia. Electrophysiologic measurements in Wolff-Parkinson-White syndrome and AV node re-entry tachycardia].
    Manz M, Kuhl AJ, Lüderitz B.
    Z Kardiol; 1985 Sep; 74(9):500-5. PubMed ID: 4060827
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of action of sotalol in supraventricular arrhythmias.
    Brugada P, Smeets JL, Brugada J, Farré J.
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():619-23. PubMed ID: 2275892
    [Abstract] [Full Text] [Related]

  • 7. Sotalol in patients with Wolff-Parkinson-White syndrome.
    Kunze KP, Schlüter M, Kuck KH.
    Circulation; 1987 May; 75(5):1050-7. PubMed ID: 3568305
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of sotalol in controlling reentrant supraventricular tachycardias.
    Millar RN.
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():625-9. PubMed ID: 2275893
    [Abstract] [Full Text] [Related]

  • 9. Effects of intravenous sotalol in patients with atrioventricular accessory pathways.
    Touboul P, Atallah G, Kirkorian G, Lavaud P, Mathieu MP, Dellinger A.
    Am Heart J; 1987 Sep; 114(3):545-50. PubMed ID: 3630895
    [Abstract] [Full Text] [Related]

  • 10. Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
    Luedtke SA, Kuhn RJ, McCaffrey FM.
    Ann Pharmacother; 1997 Oct; 31(10):1227-43. PubMed ID: 9337449
    [Abstract] [Full Text] [Related]

  • 11. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias.
    Hohnloser SH, Zabel M.
    Am J Cardiol; 1992 Aug 20; 70(5):3A-9A; discussion 9A-10A. PubMed ID: 1387287
    [Abstract] [Full Text] [Related]

  • 12. Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group.
    Sung RJ, Tan HL, Karagounis L, Hanyok JJ, Falk R, Platia E, Das G, Hardy SA.
    Am Heart J; 1995 Apr 20; 129(4):739-48. PubMed ID: 7900626
    [Abstract] [Full Text] [Related]

  • 13. Effects of sotalol and d-sotalol on ventricular tachycardia and fibrillation induced by programmed electrical stimulation.
    Aliot E, Sadoul N, De Chillou C.
    Eur Heart J; 1993 Nov 20; 14 Suppl H():74-7. PubMed ID: 7904940
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of supraventricular tachyarrhythmias: drugs or ablation?].
    Chimienti M, Barbieri S.
    G Ital Cardiol; 1996 Feb 20; 26(2):213-26. PubMed ID: 8666179
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Using the right drug: a treatment algorithm for regular supraventricular tachycardias.
    Lévy S, Ricard P.
    Eur Heart J; 1997 May 20; 18 Suppl C():C27-32. PubMed ID: 9152672
    [Abstract] [Full Text] [Related]

  • 17. Summary of efficacy and safety of flecainide for supraventricular arrhythmias.
    Anderson JL, Jolivette DM, Fredell PA.
    Am J Cardiol; 1988 Aug 25; 62(6):62D-66D. PubMed ID: 3136638
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Results of oral sotalol therapy in children with supraventricular and ventricular arrhythmias].
    Paul T, Lehmann C, Pfammatter JP, Kallfelz HC.
    Z Kardiol; 1994 Dec 25; 83(12):891-7. PubMed ID: 7531374
    [Abstract] [Full Text] [Related]

  • 20. Atrial fibrillation in Wolff-Parkinson-White syndrome: reversal of isoproterenol effects by sotalol.
    Madrid AH, Moro C, Maŕin Huerta EM, Novo L, Mestre JL.
    Pacing Clin Electrophysiol; 1992 Nov 25; 15(11 Pt 2):2111-5. PubMed ID: 1279609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.